BioNano Genomics's total assets for Q3 2024 were $87.36M, a decrease of -32.47% from the previous quarter. BNGO total liabilities were $38.49M for the fiscal quarter, a -21.48% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.